Lead Statistical Programmer for Global Phase I-IV Trials

IQVIA Inc

Lombardia

On-site

EUR 90,000 - 120,000

Full time

20 hours ago
Be an early applicant

A complete application in a minute

Tailored resume and cover letter, ready to send.

Get past ATS filters

Job summary

IQVIA is seeking a Senior Statistical Programmer to join our global FSP team supporting Phase I–IV clinical trials. You will lead programming activities, develop TLFs, and ensure CDISC-compliant deliverables for regulatory submissions.

The role requires 5+ years in pharma/biotech, strong SAS and R skills, and experience as Study Lead or Lead Programmer. You will collaborate across Biostatistics, Data Management, and cross-functional teams to drive global programs.

Qualifications

  • Bachelor's or Master's degree in Statistics, Mathematics, Computer Science, Life Sciences, or related field.
  • Minimum 5 years of statistical programming experience in pharma/biotech/CRO.
  • Strong SAS (Base & Macro) and R programming experience.
  • Knowledge of CDISC standards (SDTM/ADaM) and Pinnacle 21.
  • Experience supporting efficacy analyses and regulatory deliverables.
  • Experience as Study Lead or Lead Programmer on global trials.

Responsibilities

  • Lead programming activities across Phase I–IV trials.
  • Develop, validate, and maintain analysis datasets, TLFs, and figures using SAS and R.
  • Support efficacy and safety analyses per CDISC standards.
  • Author and review programming specifications and documentation.
  • QC/validate programming outputs and ensure regulatory compliance.
  • Collaborate with Biostatistics, Data Management and cross-functional teams.
  • Provide oversight and technical guidance as Lead Programmer or Study Lead.

Skills

SAS Base/Macro
R programming
CDISC SDTM/ADaM
Pinnacle 21

Education

Bachelor's or Master's in Statistics/Math/CS/Life Sciences

Job description

IQVIA is seeking a Senior Statistical Programmer to join our global FSP team supporting Phase I–IV clinical trials. You will lead programming activities, develop TLFs, and ensure CDISC-compliant deliverables for regulatory submissions.

The role requires 5+ years in pharma/biotech, strong SAS and R skills, and experience as Study Lead or Lead Programmer. You will collaborate across Biostatistics, Data Management, and cross-functional teams to drive global programs.

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Principal Statistical Programmer & Study Lead (SAS/R)
Principal Statistical Programmer & Study Lead (SAS/R)

IQVIA Inc • Lombardia

On-site
EUR 110,000 - 150,000
Senior Statistical Programmer (FSP - Permanent Homebased) m/w/d
Senior Statistical Programmer (FSP - Permanent Homebased) m/w/d

IQVIA Inc • Lombardia

On-site
EUR 90,000 - 120,000
Principal Statistical Programmer (FSP - Permanent Homebased) m/w/d
Principal Statistical Programmer (FSP - Permanent Homebased) m/w/d

IQVIA Inc • Lombardia

On-site
EUR 110,000 - 150,000
Lead Statistical Programmer – SAS, CDISC, Remote
Lead Statistical Programmer – SAS, CDISC, Remote

Chiesi Farmaceutici S.p.A. • Parma

Hybrid
EUR 41,400 - 50,600
Annual bonus
Relocation support
Private medical insurance
Global Clinical Project Lead (CFSP)
Global Clinical Project Lead (CFSP)

IQVIA Inc • Lombardia

On-site
EUR 90,000 - 120,000
Senior Biostatistician: Lead Analyses for Clinical Programs
Senior Biostatistician: Lead Analyses for Clinical Programs

Recordati • Lombardia

On-site
EUR 59,000 - 72,000
Statistical Scientist Director
Statistical Scientist Director

44 Premier Research S.r.l. • Italy

On-site
EUR 70,000 - 100,000
Associate Director Statistical Programming
Associate Director Statistical Programming

Warman O'Brien • Lombardia

Hybrid
EUR 180,000 - 240,000
Hybrid work model
Global Clinical Trial Lead: Strategy & Delivery
Global Clinical Trial Lead: Strategy & Delivery

IQVIA Inc • Lombardia

On-site
EUR 53,000 - 80,000
Global Clinical Trial Delivery Lead
Global Clinical Trial Delivery Lead

IQVIA Inc • Milano

On-site
EUR 90,000 - 130,000